✦ LIBER ✦

Efficacy and safety of carvedilol in comparison with atenolol in hypertensive patients pretreated with hydrochlorothiazide

✍ Scribed by R. van der Does; L. Widmann; H. -J. Überbacher; M. Hörrmann; M. Machwirth; U. Stienen

Publisher: Springer
Year: 1990
Tongue: English
Weight: 641 KB
Volume: 38
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf01409486

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and antihypertensive efficacy of

Safety and antihypertensive efficacy of carvedilol and atenolol alone and in combination with hydrochlorothiazide

✍ L. Widmann; R. van der Does; M. Hörrmann; M. Machwirth 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 362 KB

A comparison of labetalol and prazosin c

A comparison of labetalol and prazosin combined with atenolol in non-responders to atenolol plus hydrochlorothiazide in uncomplicated hypertension

✍ E. Veur; B. S. Berge; A. J. M. Donker; J. F. May; F. H. Schuurman; H. Wesseling 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 670 KB

Ticrynafen and hydrochlorothiazide a com

Ticrynafen and hydrochlorothiazide a comparison in hypertensive patients with renal impairment

✍ B. T. Emmerson; P. J. Renshaw; P. J. Ravenscroft; I. Denham; S. Schey 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 531 KB

A comparison of the efficacy of cilazapr

A comparison of the efficacy of cilazapril versus cilazapril plus hydrochlorothiazide in patients with mild to moderate essential hypertension

✍ G. S. M. Kellaway 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 223 KB

Effects of hydrochlorothiazide and capto

Effects of hydrochlorothiazide and captopril on lipoprotein lipid composition in patients with essential hypertension

✍ J. D. Bagdade; W. F. Buchanan; T. Pollare; H. Lithell 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 449 KB

Objective: Effective antihypertensive agents may differ in their capacity to reduce cardiovascular risk because they induce potentially atherogenic alterations in lipoprotein composition. Patients: To assess this possibility, the effects of five months' treatment with either hydrochlorothiazide (HCT

Efficacy and safety of bortezomib in pat

Efficacy and safety of bortezomib in patients with plasma cell leukemia

✍ Pellegrino Musto; Fausto Rossini; Francesca Gay; Vincenzo Pitini; Tommasina Gugl 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 1 views

## Abstract ## BACKGROUND. The prognosis of patients with plasma cell leukemia (PCL), an aggressive variant of multiple myeloma (MM), is usually poor. Bortezomib is the first proteasome inhibitor approved for the treatment of advanced MM. Currently available information regarding the role of borte